• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

vaccine

	Next higher product group	pharmaceutical
	Status	1998-01-01 sales existent

Record changed: 2021-05-05

Advertisement

More documents for vaccine

• [1] Valneva S.E.. (5/10/21). "Press Release: Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to $107.6 Million". Saint-Herblain....
• [2] Valneva S.E.. (4/29/21). "Press Release: Valneva Announces Launch of Proposed Global Offering, Start of the Roadshow and Nasdaq Listing". Saint-Herblain....
• [3] DNA Script. (4/27/21). "Press Release: DNA Script Partners with Moderna to Develop On-Demand Vaccines and Therapeutics for DARPA". Paris & Cambridge, MA....
• [4] Valneva S.E.. (4/6/21). "Press Release: Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001". Saint-Herblain....
• [5] ProBioGen AG. (3/24/21). "Press Release: ProBioGen Enters into Agreement with Nobelpharma for Manufacturing Process Development of their Vaccine Project". Berlin....
• [6] Selexis S.A.. (3/18/21). "Press Release: SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies to Advance Human Cytomegalovirus VLP Vaccine Program". Geneva....
• [7] Vaccitech Ltd.. (3/17/21). "Press Release: Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results". Oxford....
• [8] Leukocare AG. (3/1/21). "Press Release: Leukocare and Malvern Collaborate on Stabilization and Formulation Development of COVID-19 Vaccines". Martinsried & Malvern....
• [9] CureVac N.V.. (2/12/21). "Press Release: CureVac Initiates Rolling Submission with European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA....
• [10] Evonik Industries AG. (2/11/21). "Press Release: Evonik Strengthens Strategic Partnership with BioNTech on COVID-19 Vaccine". Essen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.